Global Transplant Market - Forecasts from 2018 to 2023

Global Transplant Market - Forecasts from 2018 to 2023

The global transplant market is projected to grow at a CAGR of XX.XX% to reach US$XX.XXX billion by 2023, from US$XX.XXX billion in 2017. Transplants are also known as grafts or organ transplants where a section of a tissue or a complete organ from its original site is transferred to the area of interest in an individual (same or separate). Thus, the transplanted organ or graft continue to receive nourishment from the new and healthy environment. Prevalence of chronic diseases is one of the major factors driving the growth of the global transplant market in the forecast period. Furthermore, growing health awareness along with government initiatives regarding organ donation is driving the market growth. However, the shortage of organ donors and incidences of transplant rejection may impede the growth of the global transplant market in the forecast period. Additionally, technological advancements will drive market growth in the coming years and beyond.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global transplant value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global transplant market.

Major industry players profiled as part of the report are Transplant Biomedicals, Sandor, Veloxis Pharmaceuticals, Inc., Scanlan International and Bridge to Life Ltd. among others.

Segmentation

The global transplant market has been analyzed through following segments:

By Type

Tissue Transplant

Organ Transplant


By Procedure

Autotransplantation

Allotransplantation

Xenotransplantation


By Product

Immunosuppresive drugs

Preservation Solutions

Tissue Products

Transplant Instruments


By Geography

North America

USA

Canada

Mexico

Others


South America

Brazil

Argentina

Others


Europe

Germany

France

United Kingdom

Spain

Others


Middle East and Africa

Saudi Arabia

Israel

Others


Asia Pacific

China

Japan

South Korea

India

Others


Target audience

Manufacturers

Suppliers

Distributors

Service Providers

Government Agencies

Research Organizations

Consultants


Key insights offered

What will be the global transplant market size from 2017 to 2023?

How are the major drivers and restraints affecting the global transplant market growth and the opportunities which exist for key vendors?

Which segment and region will drive or lead the market growth and why?

A comprehensive analysis of competitive landscape and key market participants’ behaviour

Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY  
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. GLOBAL TRANSPLANT MARKET BY TYPE
5.1. Tissue Transplant
5.2. Organ Transplant
6. GLOBAL TRANSPLANT MARKET BY PROCEDURE
6.1. Autotransplantation
6.2. Allotransplantation
6.3. Xenotransplantation
7. GLOBAL TRANSPLANT MARKET BY PRODUCT
7.1. Immunosuppresive drugs
7.2. Preservation Solutions
7.3. Tissue Products
7.4. Transplant Instruments
8. GLOBAL TRANSPLANT MARKET BY GEOGRAPHY
8.1. North America
8.1.1. USA
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentia
8.2.3. Others
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. United Kingdom
8.3.4. Spain
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. Israel
8.4.3. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. South Korea
8.5.4. India
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1.  Market Share of Key Players
9.2.  Recent Investment and Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. MIROMATRIX MEDICAL INC.
10.1.1. Company Overview
10.1.2. Financials
10.1.3. Products and Services
10.1.4. Recent Developments
10.2. Transplant Biomedicals
10.2.1. Company Overview
10.2.2. Financials
10.2.3. Products and Services
10.2.4. Recent Developments
10.3.  Sandor
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Products and Services
10.3.4. Recent Developments
10.4. Veloxis Pharmaceuticals, Inc.
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Products and Services
10.4.4. Recent Developments
10.5.  Scanlan International
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Products and Services
10.5.4. Recent Developments
10.6. Bridge to Life Ltd.
10.6.1. Company Overview
10.6.2. Financials
10.6.3. Products and Services
10.6.4. Recent Developments
10.7. Medistim International
10.7.1. Company Overview
10.7.2. Financials
10.7.3. Products and Services
10.7.4. Recent Developments
10.8. PARAGONIX TECHNOLOGIES INC.
10.8.1. Company Overview
10.8.2. Financials
10.8.3. Products and Services
10.8.4. Recent Developments
10.9. Global Transplant Solutions
10.9.1. Company Overview
10.9.2. Financials
10.9.3. Products and Services
10.9.4. Recent Developments
10.10. XVIVO Perfusion
10.10.1. Company Overview
10.10.2. Financials
10.10.3. Products and Services
10.10.4. Recent Developments
LIST OF FIGURES
LIST OF TABLES
DISCLAIMER 

MIROMATRIX MEDICAL INC.

Transplant Biomedicals

Sandor

Veloxis Pharmaceuticals, Inc.

Scanlan International

Bridge to Life Ltd.

Medistim International

PARAGONIX TECHNOLOGIES INC.

Global Transplant Solutions

XVIVO Perfusion

  • SKU:
  • Publishing Date: 2018-12-27
  • Product Code: 1
  • Availability: In Stock
  • $3,950.00
  • Ex Tax: $3,950.00

Available Options